Hit all the right notes, good synopsis. Good also to hear Tina Brown is still alive and high-kicking.
Another sign the trans-gender fad is fading, Pfizer just recently got RFKJr back into selling these very same gender-dysphoria female hormone drugs to menopause women again, after their own WHI study in the 1990's thoroughly documented their now well established long term harms.
That 1990's studies then required Pfizer to go seeking new markets with short memory spans to keep the profits flowing from pushing their prior lifetime use for post-menopause women when they lost that market after the WHI study findings left them no place else to hide.
Enter the pre-pubescent gender dysphoria crowd. They had a new hit - life time use for drugging growing numbers of young boys to pretend they are life time women. A marketing angle made in heaven for Pfizer, if they could grow those numbers. And for a while, they did.
What did the FDA Women's Health Initiative (WHI) study in fact find out back in the 1990's, from the FDA's own website:
"The WHI showed that using estrogen plus progestin hormone therapy after menopause raised the risk of heart disease, stroke, blood clots, breast cancer, and dementia.
Hormone therapy with estrogen alone had some benefits for younger women who had a prior hysterectomy. However, estrogen raised the risk of stroke and blood clots for these women and others in the study.
This initiative helped establish that hormone therapy—estrogen plus progestin or estrogen alone—should not be used in postmenopausal women to prevent heart disease or to lower cholesterol levels. "
Hit all the right notes, good synopsis. Good also to hear Tina Brown is still alive and high-kicking.
Another sign the trans-gender fad is fading, Pfizer just recently got RFKJr back into selling these very same gender-dysphoria female hormone drugs to menopause women again, after their own WHI study in the 1990's thoroughly documented their now well established long term harms.
That 1990's studies then required Pfizer to go seeking new markets with short memory spans to keep the profits flowing from pushing their prior lifetime use for post-menopause women when they lost that market after the WHI study findings left them no place else to hide.
Enter the pre-pubescent gender dysphoria crowd. They had a new hit - life time use for drugging growing numbers of young boys to pretend they are life time women. A marketing angle made in heaven for Pfizer, if they could grow those numbers. And for a while, they did.
What did the FDA Women's Health Initiative (WHI) study in fact find out back in the 1990's, from the FDA's own website:
"The WHI showed that using estrogen plus progestin hormone therapy after menopause raised the risk of heart disease, stroke, blood clots, breast cancer, and dementia.
Hormone therapy with estrogen alone had some benefits for younger women who had a prior hysterectomy. However, estrogen raised the risk of stroke and blood clots for these women and others in the study.
This initiative helped establish that hormone therapy—estrogen plus progestin or estrogen alone—should not be used in postmenopausal women to prevent heart disease or to lower cholesterol levels. "
Falling off my chair......*laugh*
Get on your sleigh and wait your turn? WELL DONE.